Travelers’ Diarrhea Vaccine Patch Fails in Trials

Intercell AG plunged as much as 47 percent in Vienna trading after a vaccine patch to prevent diarrhea in travelers failed in two patient studies, prompting the company to forecast a wider loss.
Bloomberg